Pharma's Image Fix: Lessons from the Field
Pharm Exec chronicles the military-industry effort to instill the principles of adaptive leadership into today’s pharma leader-a C-suite must in reviving the industry’s beleaguered reputation.
The Innovation Distinction: Biopharma's Reputational Pass
The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.
Valeant’s Northern Face
Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally.
More New Drugs and Generics Reshape Pharma Markets
Low-cost follow-ons and biosimilars please payers but heighten competitive battles with brands.
Leadership in All the Right Places
Drawing parallels from the world of football coaching in evaluating and grooming future C-suite pharma leaders-call it the quest to see "what right looks like?"
Industry Engine Check
2017 was a year of swings and momentum for the pharma and biotech markets. Is more stable footing ahead?
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
